PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.

683 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Nanoparticle PEGylation for imaging and therapy (2011, background): “Other techniques prepare hydrophobic polymeric NPs [109], oleic acid-coated magnetic NPs [110] or QDs [111] coated with PEGylated lipids.”
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come (2016, methodology): “Only when DSPEPEG2000Da was added to the lipid formulation were LPNs more stable (Chan et al., 2009).”
Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation (2010, background): “Lipid-based carriers pose several challenges, such as instability of the carrier, initial burst drug release, and rapid blood clearance by the RES, mostly the liver and spleen, in a short period of time.(24,123,142) To improve the stability and prevent opsonization by the liver, the surface of lipos”
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery (2015, neutral): “Additionally Vitamin-E-TPGS-PEG [214-218], fatty-acid-PEG esters [219], phospholipidPEG [220] and others can be absorbed on polymeric nanoparticles and inorganic nanoparticles to form a PEG corona.”